The study concluded that the combination of nelfinavir and ritonavir effectively kills bladder cancer cells through multiple mechanisms, including ER stress induction, mTOR pathway inhibition, and histone acetylation, making it a promising therapeutic strategy for bladder cancer [76]. Here, MTOR is linked to urinary bladder cancer.